How do we bring this home? How do we, collectively, payers, life sciences manufacturers and Optum, do this well?
We’d love to talk to others, just to share ideas, or to find ways to partner with manufacturers and payers in this space. The promise that gene and cell therapies hold for patients is real, and we are excited to work together to ensure that patients have affordable access to these transformative therapies.
Optum is committed to providing solutions that get the right treatments to the right patients at the right time — to meaningfully and measurably improve clinical outcomes and quality of life for patients.
Together, we can reshape health care for the good of all as we continue to innovate and connect disparate parts of the health system.
Thank you, Erin, for the discussion today.
Optum is committed to our mission, and we have all the core capabilities required to do this well. That includes deep experience using real-world data for health economics and outcomes research expertise, robust data assets and the scale of Optum. This puts us in a unique position to support value-based contracts.